| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 87,387 | 105,543 | 60,291 | | Cost of Revenue | 81,501 | 94,976 | 56,762 | | | Gross Profit | 5,887 | 10,567 | 3,528 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,400 | 12,945 | 11,846 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (5,514) | (2,378) | (8,318) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 94 | (106) | 7,557 | | Earnings Before Interest And Taxes | (5,419) | (2,830) | (761) | | Interest Expense |
-
|
-
| 0 | | Income Before Tax | (5,419) | (2,830) | (761) | | Income Tax Expense | 421 | 1,597 | 483 | | Minority Interest |
-
|
-
| 77 | | | | Net Income From Continuing Ops | (5,840) | (4,427) | (1,167) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (5,840) | (4,427) | (1,167) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,840) | ($4,427) | ($1,167) |
|
0.18% Nasdaq 0.00%
Income Statement
